clinical trials for glp-1 Discover How Are Not One-Size-Fit-All Summaries of landmark trials with

Patients should be counselled about recognising hypoglycaemia if GLP-1 receptor agonists are used in combination with insulin or sulphonylureas

Weight-loss results are not guaranteed

2026 May 4;17(5):963-972

Research has shown that it can significantly lower abdominal fat levels in people with HIV-associated lipodystrophy and may offer similar benefits for healthy individuals aiming to reduce stubborn belly fat

Until such data exist, the current results should be regarded as hypothesis-generating and a useful warning against indiscriminate use of glutathione in chronic liver disease

Without early treatment, the inflammation can cause organ damage, multi-organ failure and even death